China Pharma Holdings (CPHI) Debt Ratio (2010 - 2026)

China Pharma Holdings (CPHI) has reported Debt Ratio for 17 consecutive years, with 0.08 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Debt Ratio fell 73.16% year-over-year to 0.08; the trailing twelve-month figure through Jun 2026 stood at 0.08 (down 73.16% YoY), and the FY2025 full-year result was 0.11, down 55.48% from the prior year.
• Debt Ratio improved to 0.08 in Q2 2026 per CPHI's latest filing, from 0.08 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.56 in Q3 2022 and bottomed at 0.08 in Q1 2026.
• Historically, Debt Ratio has averaged 0.24 across 5 years, with a median of 0.22 in 2023.
• The sharpest annual moves came in 2022 and 2026: Debt Ratio jumped 541.5% in 2022, then tumbled 73.16% in 2026.
• Over 5 years, Debt Ratio stood at 0.35 in 2022, then sank by 36.33% to 0.22 in 2023, then rose by 10.67% to 0.25 in 2024, then plunged by 55.48% to 0.11 in 2025, then declined by 26.76% to 0.08 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.08, 0.08, and 0.11 for Q2 2026, Q1 2026, and Q4 2025 respectively.